UCB Pharma Asia Pacific Sdn Bhd

UCB is building the next generation biopharmaceutical leader, based on unique blending of innovation, entrepreneurship and proven experience bringing to specialists first, new medicines to treat patients suffering from severe diseases.

UCB is driven by the passionate desire to help patients and their families living with severe diseases to enjoy more normal, everyday lives. Operating in more than 40 countries, UCB specialises in novel solutions for central nervous system disorders, allergy and respiratory diseases, immune and inflammatory disorders, as well as oncology.